ArticleJournal of the American Society of Nephrology : JASN2015
Arteriovenous fistula placement in the elderly: when is the optimal time?
Article in Journal of the American Society of Nephrology : JASN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 72 citations in OpenAlex.
- UK Kidney Association Clinical Practice Guideline on vascular access for haemodialysis.BMC nephrology · 2025Guideline
- The vascular access in the elderly: a position statement of the Vascular Access Working Group of the Italian Society of Nephrology.Journal of nephrology · 2016Guideline
- Derivation and Validation of a Machine Learning Model for the Prevention of Unplanned Dialysis.Clinical journal of the American Society of Nephrology : CJASN · 2024Article
- Enhancing vascular access planning in CKD: validating the 40% KFRE threshold for predicting ESKD in a French retrospective cohort study.Clinical kidney journal · 2024Article
- Out-Patient versus In-Patient Arteriovenous Fistula Creation for Dialysis: Assessing Cost-Effectiveness Alongside Clinical Implications.Healthcare (Basel, Switzerland) · 2024Article
- Association between Timing of Vascular Access Creation and Mortality in Patients Initiating Hemodialysis: A Nationwide Cohort Study in Japan.American journal of nephrology · 2024Article
- Article
- Article
- Comparison of a Kidney Replacement Therapy Risk Score Developed in Kaiser Permanente Northwest vs Estimated Glomerular Filtration Rate in Advanced Chronic Kidney Disease Using Decision Curve Analysis.The Permanente journal · 2021Article
- Predialysis predictors for identifying patients requiring dialysis at a higher glomerular filtration rate.Renal failure · 2021Article
- The arteriovenous access stage (AVAS) classification.Clinical kidney journal · 2021Article
- Assessment of Use of Arteriovenous Graft vs Arteriovenous Fistula for First-time Permanent Hemodialysis Access.JAMA surgery · 2019Article
- Initiation of maintenance hemodialysis through central venous catheters: study of patients' perceptions based on a structured questionnaire.BMC nephrology · 2019Article
- Timing of Fistula Creation and the Probability of Catheter-Free Use: A Cohort Study.Canadian journal of kidney health and disease · 2019Article
- Tradeoffs in Vascular Access Selection in Elderly Patients Initiating Hemodialysis With a Catheter.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2018Article
- Association of Proteinuria with Central Venous Catheter Use at Initial Hemodialysis.The Permanente journal · 2018Article
- Vascular access conversion and patient outcome after hemodialysis initiation with a nonfunctional arteriovenous access: a prospective registry-based study.BMC nephrology · 2017Article
- The Effect of Predialysis Fistula Attempt on Risk of All-Cause and Access-Related Death.Journal of the American Society of Nephrology : JASN · 2017Article
- Predictors of nonfunctional arteriovenous access at hemodialysis initiation and timing of access creation: A registry-based study.PloS one · 2017Article
- A new model of an arteriovenous fistula in chronic kidney disease in the mouse: beneficial effects of upregulated heme oxygenase-1.American journal of physiology. Renal physiology · 2016Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis (HD). However, many AVFs fail before starting dialysis. To assess the optimal time for AVF placement in the elderly, we linked data from the US Renal Data System with Medicare claims data to identify 17,511 patients ≥67 years old on incident HD who started dialysis between January 1, 2005, and December 31, 2008, with an AVF placed as the first predialysis access. AVF success was defined as dialysis initiation using the AVF, with time between AVF placement and dialysis start as our primary variable of interest. The mean age was 76.1±6.0 years, and 58.3% of subjects were men. Overall, 54.9% of subjects initiated dialysis using an AVF, and 45.1% of subjects used a catheter or graft. The success rate increased as time from AVF creation to HD initiation increased from 1-3 months (odds ratio [OR], 0.49; 95% confidence interval [95% CI], 0.44 to 0.53) to 3-6 months (OR, 0.93; 95% CI, 0.85 to 1.02) to 6-9 months (OR, 0.99; 95% CI, 0.88 to 1.11) but stabilized after that time. Furthermore, the number of interventional access procedures increased over time starting at 1-3 months, with a mean of 0.64 procedures/patient for AVFs created 6-9 months predialysis compared with 0.72 for AVFs created >12 months predialysis (P<0.001). Although limited by the observational nature of this study, our results suggest that placing an AVF >6-9 months predialysis in the elderly may not associate with a better AVF success rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.